As of 2024-12-13, the EV/EBITDA ratio of CellaVision AB (CEVI.ST) is 27.87. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CEVI.ST's latest enterprise value is 5,264.31 mil SEK. CEVI.ST's TTM EBITDA according to its financial statements is 188.88 mil SEK. Dividing these 2 quantities gives us the above CEVI.ST EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 10.6x - 20.9x | 15.6x |
| Forward P/E multiples | 13.4x - 20.5x | 16.8x |
| Fair Price | 88.55 - 217.95 | 153.63 |
| Upside | -60.6% - -3.1% | -31.7% |
| Date | EV/EBITDA |
| 2024-12-10 | 27.18 |
| 2024-12-09 | 26.86 |
| 2024-12-06 | 25.72 |
| 2024-12-05 | 26.10 |
| 2024-12-04 | 26.23 |
| 2024-12-03 | 26.48 |
| 2024-12-02 | 26.61 |
| 2024-11-29 | 27.05 |
| 2024-11-28 | 27.74 |
| 2024-11-27 | 27.43 |
| 2024-11-26 | 26.55 |
| 2024-11-25 | 27.43 |
| 2024-11-22 | 26.86 |
| 2024-11-21 | 26.55 |
| 2024-11-20 | 26.17 |
| 2024-11-19 | 27.11 |
| 2024-11-18 | 27.87 |
| 2024-11-15 | 29.13 |
| 2024-11-14 | 28.88 |
| 2024-11-13 | 29.64 |
| 2024-11-12 | 30.08 |
| 2024-11-11 | 30.02 |
| 2024-11-08 | 30.14 |
| 2024-11-07 | 30.40 |
| 2024-11-06 | 29.95 |
| 2024-11-05 | 29.70 |
| 2024-11-04 | 29.64 |
| 2024-11-01 | 28.63 |
| 2024-10-31 | 28.88 |
| 2024-10-30 | 29.77 |
| 2024-10-29 | 30.59 |
| 2024-10-28 | 31.85 |
| 2024-10-25 | 32.35 |
| 2024-10-24 | 34.75 |
| 2024-10-23 | 34.25 |
| 2024-10-22 | 34.31 |
| 2024-10-21 | 34.69 |
| 2024-10-18 | 35.07 |
| 2024-10-17 | 34.37 |
| 2024-10-16 | 35.07 |
| 2024-10-15 | 36.14 |
| 2024-10-14 | 36.46 |
| 2024-10-11 | 35.89 |
| 2024-10-10 | 36.39 |
| 2024-10-09 | 36.21 |
| 2024-10-08 | 35.32 |
| 2024-10-07 | 35.32 |
| 2024-10-04 | 36.90 |
| 2024-10-03 | 36.14 |
| 2024-10-02 | 35.89 |